Clicks has reported a robust 13.7% increase in full-year headline earnings. These earnings grew to R3.2 billion for the year ended August from R2.8 billion a year ago. The strong performance was underpinned by a significant expansion of its retail and pharmacy footprint. As Clicks eyes further pharmacy expansion, it is pushing its total store base to more than 990…
Tag: Business
-
Discovery Group’s Strong Growth Delivers 30% Profit Surge
Discovery Group has reported a robust financial performance for the year ending in June. It showcased the Discovery Group’s strong growth with a 30% increase in headline earnings to R9.6 billion. A key milestone in the results was Discovery Bank achieving its first profitable period in the second half of the year. This was a significant achievement reached ahead of…
-
Novo Nordisk Hiring Freeze After Wegovy Sales Decline
Danish pharmaceutical giant Novo Nordisk, which rode a wave of unprecedented success with its weight-loss drug Wegovy, has announced a global hiring freeze for non-critical roles. This signals a dramatic shift from rapid expansion to rigorous cost-cutting. Sales begin to slow and competition intensifies. Novo Nordisk’s hiring freeze is a significant turn for the company. The Wegovy Hiring Spree The…
-
Lower Pharmaceutical Prices: Trump’s Bold Ultimatum
President Donald Trump has dramatically escalated his campaign against high medicine costs. He issued a stark ultimatum to 17 of the world’s leading pharmaceutical firms. In a move aimed at achieving lower pharmaceutical prices, the President demanded that they slash prices for American consumers. He wants them to match what is paid in other developed nations, setting a 60-day deadline…
-
Ozempic and Mounjaro are reshaping South Africa’s health market
The landscape of weight management and diabetes treatment in South Africa is undergoing a dramatic transformation. This change is driven by the meteoric rise in popularity of a class of drugs known as GLP-1s, including Ozempic and Mounjaro. These medications, initially developed for Type 2 diabetes, have shown significant efficacy in promoting weight loss. As a result, there is unprecedented…
-
Discovery reports a 34% increase in first-half earnings
Discovery has revealed a robust 34% increase in its first-half headline earnings, showcasing its strong growth trajectory. This surge is primarily attributed to the exceptional performance of its South African health insurance division and the globally recognised Vitality programme. Key Financial Highlights: Headline Earnings: Increased by 34% to R4.35 billion (£234 million) for the six months ending December, rising from…